Euro Stars 2023
Our Fixed Income team was recently awarded a solid ranking in the Euro Stars 2023 guide, CityWire's annual list of Europe's top-performing fund managers.
- Top ranking, Fixed Income, Norwegian Bonds
- #141 overall across all asset classes
Methodology for Euro Stars ranking:
The Euro Stars guide is based on a fund manager’s track record over the last three years. This performance is calculated using total returns, priced at bid to bid, with income reinvested at the ex-dividend date. The managers are then ranked using the Citywire Manager Ratio, which is a modified version of the Information Ratio that factors in all the eligible funds across all asset classes and sectors an individual runs over that time period.
The data used covers the three years to 28 February 2023.
In order to be eligible, a manager must have been active for a minimum of three years within the prescribed timeframe and be active at the end of that period. The manager must also be currently active in managing funds registered for sale in at least three of the following countries: UK, Ireland, Luxembourg, Austria, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Belgium, Denmark, Estonia, Finland, Latvia, Lithuania, Norway, Poland, Portugal, Cyprus, Gibraltar, Guernsey, Isle of Man, Jersey, Liechtenstein and Malta.
Once the eligibility criteria above are met, the top 250 managers ranked by Manager Ratio are awarded a Euro Stars rating.
This elite group are then arranged by the sectors in which they run funds, in order of their respective Manager Ratio, which is measured across all Euro Stars funds managed (find the full tables at the back). Each manager profile includes the total assets under management across all funds they run in that respective sector.
Latest news
Arctic Asset Management - Revolution Medicines announced unprecedented Phase 3 results in pancreatic cancer
Arctic Aurora LifeScience holding, Revolution Medicines announced outstanding overall survival benefit in metastatic pancreatic cancer, one of the most lethal tumors.
Arctic Asset Management - Markedskommentar mars 2026
Markedene i mars ble påvirket av krigen i Iran som har spredt seg til store deler av Midtøsten og skapt betydelige globale ringvirkninger. Etter at USA og Israel angrep Iran på den siste dagen i februar, har regionen vært preget av krigshandlinger, med påfølgende avbrudd i råvareproduksjon og forsyningskjeder som har gitt økt markedsvolatilitet.
Arctic Asset Management - No slowing down of Biotech M&A: Soleno to be acquired by Neurocrine
On April 6, Arctic Aurora LifeScience holdings Soleno Therapeutics and Neurocrine Biosciences announced an agreement in which the mid-cap commercial biotech Neurocrine acquires Soleno for USD 2.9 billion or USD 53 per share - a 34% premium over the last closing price.
Arctic Asset Management - Apellis to be acquired by Biogen for 140% premium
On March 31, Arctic Aurora LifeScience portfolio company Apellis Pharmaceuticals announced that the company had agreed to be acquired by Biogen for an upfront cash consideration of USD 5.6 billion, representing a 140% premium on the latest closing price.
Arctic Asset Management - Arctic Midt i Måneden - Global uro, energisjokk og markedsmuligheter
Geopolitisk uro, stigende energipriser og økt markedsvolatilitet preger finansmarkedene i mars. Hva betyr dette for renter, aksjer og investorers posisjonering fremover? I denne episoden av Arctic Midt i Måneden diskuterer Albert Collett sammen med Cathrine Foyn, Tone Varmann og Alexander Larstedt Lager hvordan krig og usikkerhet påvirker markedene – og hvor mulighetene kan ligge i en urolig tid.
Arctic Asset Management - Unlocking Alpha in Biotech Through Active Selection
Yesterday, two companies in the Arctic Aurora LifeScience portfolio reported positive clinical data, which was rewarded by the market. Clinical execution and identifying companies with differentiated drug candidates yields excess returns, as demonstrated by Xenon's share price, which appreciated by close to 50% on positive data, and Dianthus, which appreciated by 21%.